|
J Biol Chem, Vol. 274, Issue 44, 31663-31670, October 29, 1999
Cadmium Induces Conformational Modifications of Wild-type p53 and
Suppresses p53 Response to DNA Damage in Cultured Cells
Catherine
Méplan ,
Kris
Mann¶, and
Pierre
Hainaut
From the International Agency for Research on Cancer,
Unit of Mechanisms of Carcinogenesis, 150 Cours Albert Thomas, 69372 Lyon cedex 08, France and the ¶ University of Alaska,
Anchorage, Alaska 99508
The p53 tumor suppressor protein is a
transcription factor that binds DNA in a sequence-specific manner
through a protein domain stabilized by the coordination of zinc within
a tetrahedral cluster of three cysteine residues and one histidine
residue. We show that cadmium, a metal that binds thiols with high
affinity and substitutes for zinc in the cysteinyl clusters of many
proteins, inhibits the binding of recombinant, purified murine p53 to
DNA. In human breast cancer MCF7 cells (expressing wild-type p53), exposure to cadmium (5-40 µM) disrupts native
(wild-type) p53 conformation, inhibits DNA binding, and down-regulates
transcriptional activation of a reporter gene. Cadmium at 10-30
µM impairs the p53 induction in response to DNA-damaging
agents such as actinomycin D, methylmethane sulfonate, and hydrogen
peroxide. Exposure to cadmium at 20 µM also suppresses
the p53-dependent cell cycle arrest in G1 and
G2/M phases induced by -irradiation. These observations indicate that cadmium at subtoxic levels impairs p53 function by
inducing conformational changes in the wild-type protein. There is
evidence that cadmium is carcinogenic to humans, in particular for lung
and prostate, and cadmium is known to accumulate in several organs.
This inhibition of p53 function could play a role in cadmium carcinogenicity.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. McElroy, M. M. Shafer, A. Trentham-Dietz, J. M. Hampton, and P. A. Newcomb
Cadmium exposure and breast cancer risk.
J Natl Cancer Inst,
June 21, 2006;
98(12):
869 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, B. Lee, and A. S. Lee
Endoplasmic Reticulum Stress-induced Apoptosis: MULTIPLE PATHWAYS AND ACTIVATION OF p53-UP-REGULATED MODULATOR OF APOPTOSIS (PUMA) AND NOXA BY p53
J. Biol. Chem.,
March 17, 2006;
281(11):
7260 - 7270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Collin-Hansen, R. A. Andersen, and E. Steinnes
Molecular defense systems are expressed in the king bolete (Boletus edulis) growing near metal smelters.
Mycologia,
September 1, 2005;
97(5):
973 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Roy, S. Mukherjee, S. Mukhopadhyay, and S. K. Das
Differential effect of cadmium on cholinephosphotransferase activity in normal and cancerous human mammary epithelial cell lines
Mol. Cancer Ther.,
February 1, 2004;
3(2):
199 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Goldschneider, E. Blanc, G. Raguenez, M. Barrois, A. Legrand, G. Le Roux, H. Haddada, J. Benard, and S. Douc-Rasy
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line
J. Cell Sci.,
January 15, 2004;
117(2):
293 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Krone and L. C. Harms
Re: Zinc Supplement Use and Risk of Prostate Cancer
J Natl Cancer Inst,
October 15, 2003;
95(20):
1556 - 1556.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Achanzar, B. A. Diwan, J. Liu, S. T. Quader, M. M. Webber, and M. P. Waalkes
Cadmium-induced Malignant Transformation of Human Prostate Epithelial Cells
Cancer Res.,
January 1, 2001;
61(2):
455 - 458.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|